Clinical trials: Erectile Dysfunction, completed
Erectile Dysfunction, Spinal Cord Injuries
Efficacy and Safety of Tadalafil in Subjects With Erectile Dysfunction Caused by Spinal Cord Injury
This is a study of the efficacy and safety of on-demand dosing of tadalafil or placebo administered for 12 weeks to men with erectile dysfunction caused by spinal cord injury.
- Trial name
- NCT00421083
- Testing
- tadalafil
- Where
- United States
- Volunteers
- 180 people
- Sponsor
- Eli Lilly and Company
Impotence, Erectile Dysfunction
Effect of Tadalafil on the Quality of Life and Sexual Life in Erectile Dysfunction
Study is a clinical study assessing the effect of oral tadalafil 10mg or 20 mg on psychosocial aspects and quality of life of erectile dysfunction patients and to compare tadalafil with previous oral erectile dysfunction…
- Trial name
- NCT00422578
- Testing
- tadalafil
- Where
- Finland
- Volunteers
- 200 people
- Sponsor
- Eli Lilly and Company
Impotence
Study For Which Treatment, Tadalafil or Sildenafil, is Preferred For Problems Getting or Maintaining an Erection
To determine if men prefer tadalafil or sildenafil for getting and keeping an erection after treatment with both drugs.
- Trial name
- NCT00547092
- Testing
- tadalafil, sildenafil
- Where
- United Kingdom
- Volunteers
- 386 people
- Sponsor
- Eli Lilly and Company
Impotence
Study the Safety and Effectiveness of Tadalafil in Men With Diabetes Who Have Problems Getting and Keeping an Erection
Study to evaluate the safety and effectiveness of 2.5 mg and 5 mg tadalafil when taken by men with diabetes mellitus who have problems getting and maintaining an erection.
- Trial name
- NCT00547183
- Testing
- tadalafil
- Where
- Germany
- Volunteers
- 298 people
- Sponsor
- Eli Lilly and Company
Impotence
Studying the Preference of Tadalafil to Sildenafil in Men With Problems Getting an Erection Across Nations
Study to determine if men from around the world prefer sildenafil to tadalafil.
- Trial name
- NCT00547287
- Testing
- tadalafil, sildenafil
- Where
- Brazil
- Volunteers
- 2,760 people
- Sponsor
- Eli Lilly and Company
Impotence
Study to Determine a Preference Between Sildenafil or Tadalafil Treatment for Problems Getting an Erection
To determine if men with problems getting and keeping an erection prefer treatment with tadalafil or sildenafil.
- Trial name
- NCT00547352
- Testing
- tadalafil, sildenafil
- Where
- South Korea
- Volunteers
- 160 people
- Sponsor
- Eli Lilly and Company
Impotence
To Determine Effect and Safety of Tadalafil Taken by Men of Different Races and With Different Diseases When Needed for Erections
To compare men of different races and those with diabetes or depression to white men that do not have diabetes or depression but also suffer from the inability to get or keep an erection.
- Trial name
- NCT00547417
- Testing
- tadalafil
- Where
- United States
- Volunteers
- 1,933 people
- Sponsor
- Eli Lilly and Company
Impotence
Study the Safety and Effectiveness of Tadalafil in Men With Problems Getting or Maintaining an Erection When Taken Prior to Desiring an Erection
Study to determine how safe and effective tadalafil is for Japanese men taking it when they need to get and keep an erection.
- Trial name
- NCT00547495
- Testing
- tadalafil
- Where
- Japan
- Volunteers
- 343 people
- Sponsor
- Eli Lilly and Company
Impotence
To Determine How Different Doses of Tadalafil Work on Getting and Keeping an Erection 26 or 36 Hours After Taking
Study to see how effective different doses of tadalafil are for getting and keeping an erection when sex is attempted after a certain number of hours.
- Trial name
- NCT00547508
- Testing
- tadalafil
- Where
- United States
- Volunteers
- 485 people
- Sponsor
- Eli Lilly and Company
Impotence
Determine Safety and Effectiveness of Tadalafil in Asian Men When Taken as Needed for Getting and Keeping an Erection
Study to determine if tadalafil works better than placebo for Asian men having trouble getting or keeping an erection.
- Trial name
- NCT00547573
- Testing
- tadalafil
- Where
- China
- Volunteers
- 367 people
- Sponsor
- Eli Lilly and Company
Impotence
Determine If the Stress That Comes With Not Developing an Erection Affects Tadalafil Effects
To determine if patients who are distressed over having problems getting or maintaining an erection react differently to the medication than those who are not stressed over the issue.
- Trial name
- NCT00547599
- Testing
- tadalafil
- Where
- Sweden
- Volunteers
- 659 people
- Sponsor
- Eli Lilly and Company
Erectile Dysfunction
Phase I Study to Investigate the Alcohol Interaction of SK3530
This study was designed to investigate the alcohol effect of SK3530 on the pharmacokinetics (PKs) and safety.
- Trial name
- NCT00489450
- Testing
- SK3530
- Where
- South Korea
- Volunteers
- 18 people, healthy volunteers welcome
- Sponsor
- SK Chemicals Co., Ltd.
Erectile Dysfunction
Phase I Study to Investigate the Drug Interaction After Oral Administration of Tamsulosin and SK3530
To assess the pharamcodynamic effects of coadministrated SK3530(PDE5 inhibitor) and tamsulosin, phase I study in healthy volunteers was designed.
- Trial name
- NCT00489606
- Testing
- SK3530
- Where
- South Korea
- Volunteers
- 16 people, healthy volunteers welcome
- Sponsor
- SK Chemicals Co., Ltd.
Erectile Dysfunction
A Study of DA-8159 in Subjects With Erectile Dysfunction
The purpose of this study will be to evaluate the clinical efficacy and safety of DA-8159, an orally administered, potent and selective inhibitor of PDE5, versus placebo for the treatment of subjects with erectile dysfunction…
- Trial name
- NCT00282607
- Testing
- DA-8159
- Where
- 15 sites in United States
- Volunteers
- 300 people
- Sponsor
- Dong-A PharmTech Co., Ltd.
Impotence
A Randomized Double Blind, Placebo Controlled Balanced 4-Way Crossover Study To Assess The Efficacy Of Single Oral Doses
The primary aim of this study is to assess how effective PF-00592379 is in restoring penile erections in patients with erectile dysfunction.
- Trial name
- NCT00273416
- Testing
- PF-00592379, Sildenafil 100mg
- Where
- 2 sites in Norway, United Kingdom
- Volunteers
- 32 people
- Sponsor
- Pfizer
Impotence
Assessment of Onset, Safety & Toleration of UK-369,003 in Male Erectile Dysfunction
To determine the onset of action, safety and toleration of different formulations and doses of UK-369,003 in patients with erectile dysfunction.
- Trial name
- NCT00141349
- Testing
- UK-369,003
- Where
- 39 sites in United States
- Volunteers
- 300 people
- Sponsor
- Pfizer
Impotence
Assessment Of Duration Of Action, Safety & Toleration Of UK369,003 and Cialis In Patients With Erectile Dysfunction
Assessment of duration of action, safety \& toleration of different formulations and doses of UK-369,003 and Cialis in patients with male erectile dysfunction.
- Trial name
- NCT00174486
- Testing
- UK0369,003, Cialis (Tadalafil)
- Volunteers
- 300 people
- Sponsor
- Pfizer
Prostate Cancer, Erectile Dysfunction
A Study to Assess the Efficacy of Tadalafil to Treat Erectile Dysfunction After Radiotherapy of Prostate Cancer
This study has been designed to evaluate the efficacy and safety of a 20-mg dose of tadalafil administered "on demand" to patients with erectile dysfunction (ED) after external-beam radiotherapy (EBRT) of prostate cancer.
- Trial name
- NCT00122499
- Testing
- tadalafil
- Where
- Netherlands
- Sponsor
- Erasmus Medical Center